David Jayne
Cambridge University Hospitals NHS Foundation Trust/University of Cambridge · Cambridge University Hospitals NHS Foundation Trust · Addenbrookes Hospital, Cambridge, United Kingdom
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Jayne as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:27 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05168475 · Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisCambridge University Hospitals NHS Foundation Trust · terminated · Giant Cell Arteritis, Takayasu Arteritis, Cogan Syndrome · principal investigator
- Ph3NCT01697267 · Rituximab Vasculitis Maintenance StudyCambridge University Hospitals NHS Foundation Trust · completed · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis · study chair
- Ph3NCT01446211 · Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's GranulomatosisNordic Pharma SAS · terminated · Wegeners Granulomatosis · principal investigator
- Ph3NCT00987389 · Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisUniversity of Pennsylvania · completed · Granulomatosis With Polyangiitis (Wegener's) (GPA), Microscopic Polyangiitis (MPA) · principal investigator
- Ph3NCT00539799 · Steroids in the Maintenance of Remission of Proliferative Lupus NephritisCambridge University Hospitals NHS Foundation Trust · withdrawn · Lupus Nephritis · principal investigator
- Ph2NCT00530075 · Phase II Study on Gusperimus in Patients With Refractory Wegener's GranulomatosisNippon Kayaku Co., Ltd. · completed · Wegener's Granulomatosis · principal investigator
- Ph2/Ph3NCT00414128 · Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA VasculitisCambridge University Hospitals NHS Foundation Trust · completed · Vasculitis · principal investigator
- Ph2NCT00293072 · Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and VasculitisCambridge University Hospitals NHS Foundation Trust · completed · Systemic Lupus Erythematosus, ANCA Associated Vasculitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Plasma Exchange and Glucocorticoids for Treatment of ANCA-Associated VasculitisR01FD003516 · FDA · UNIVERSITY OF PENNSYLVANIA · PI Peter A Merkel · fiscal years 2009 to 2015Named on NCT00987389
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:27 UTC. The ranking covers the 200 most relevant of 115 PubMed records, and a shared surname and initials can bring in a namesake. All 115 on PubMed
- 2,404 citationsRCR 78.5
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med · 20101,282 citationsRCR 38.8
- Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group.J Clin Oncol · 20071,160 citationsRCR 37.4
- 1,147 citationsRCR 59.9
- A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.N Engl J Med · 2003960 citationsRCR 27.5
- Avacopan for the Treatment of ANCA-Associated Vasculitis.N Engl J Med · 2021835 citationsRCR 56.8
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.N Engl J Med · 2017815 citationsRCR 37.5
- Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.J Am Soc Nephrol · 2009804 citationsRCR 23.8
- Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.J Am Soc Nephrol · 2007775 citationsRCR 23.6
- Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer.Br J Surg · 2010755 citationsRCR 25.9